China syndrome - a regulatory framework in meltdown?

Article Abstract:

The hopes of the Chinese State Food and Drug Administration (SFDA) are dashed with tragic personal consequences for Zheng Xiaoyu and allegations of widespread corruption by Chinese officials. Zheng's execution and life imprisonment of his subordinates have highlighted the intention of the Chinese authorities to make a strong public statement that corruption will not be tolerated by the SFDA.

Legal issues & crime, Forecasts, trends, outlooks, Management dynamics, Pharmaceutical preparations, Company legal issue, Pharmaceutical industry, Investigations, Practice, Political corruption, Public officers, Government officials, Industry forecasts

---

Lack of private financing hobbles emerging biotech regions

Article Abstract:

The initiatives taken by the Governments of the largest emerging economies including China, India and Russia to develop their biotech sectors are hindered by the lack of an appropriate level of private funding. They also badly need more intellectual property protection and help for enterprise creation as well as the definition of niche areas to focus on.

Government expenditures, Drugs, India, Russia, Economic aspects, Biotechnology industry, Biotechnology industries, Research grants, Research funding, Government finance

---

Similar abstracts:

• Abstracts: Publicity and the regulator: Striking a balance. Mind the cap. E&Y faces Equitable grilling
• Abstracts: Boeing reports mixed bag of military aircraft sales. Boeing probes seen continuing, but not harming revenues
• Abstracts: Gold in the ivory tower: Equity rewards of outlicensing. Who took the tech out of biotech? The hermit crab solution
• Abstracts: The policy outlook from the Hill. Action needed to harmonize regulation of low-level presence of biotech traits
• Abstracts: Investment and financing constraints: evidence from the funding of corporate pension plans. The foundations of freezeout laws in takeovers

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.